Saudi Journal of Kidney Diseases and Transplantation

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 30  |  Issue : 4  |  Page : 825--831

Significance of paraprotein gap and β2 microglobulins in predialysis Population with multiple myeloma


Hatem Ali1, Bhuvan Kishore2, Jyoti Baharani1 
1 Department of Renal Medicine, Heart of England Teaching Hospitals, Birmingham, UK
2 Department of Hematology, Heart of England Teaching Hospitals, Birmingham, UK

Correspondence Address:
Hatem Ali
Department of Renal Medicine, Heart of England Teaching Hospitals, Birmingham
UK

Paraprotein gap is sometimes used as a screening tool in some autoimmune diseases, cancers, and screening for latent infections. The increase in the paraprotein gap in these diseases was hypothesized to be the result of increased levels of immunoglobulins, raising the total serum protein without any changes in serum albumin. Our aim was to assess the overall survival using novel chemotherapy, bortezomib compared to traditional ones and to assess if paraprotein gap could be used as a predictor of survival. Finally, we aimed to assess factors that could predict renal response in this population.


How to cite this article:
Ali H, Kishore B, Baharani J. Significance of paraprotein gap and β2 microglobulins in predialysis Population with multiple myeloma.Saudi J Kidney Dis Transpl 2019;30:825-831


How to cite this URL:
Ali H, Kishore B, Baharani J. Significance of paraprotein gap and β2 microglobulins in predialysis Population with multiple myeloma. Saudi J Kidney Dis Transpl [serial online] 2019 [cited 2020 Oct 19 ];30:825-831
Available from: https://www.sjkdt.org/article.asp?issn=1319-2442;year=2019;volume=30;issue=4;spage=825;epage=831;aulast=Ali;type=0